Oxford BioDynamics (LON:OBD) Stock Price Down 22.7% – What’s Next?

Posted by Casey Walker on Dec 6th, 2024

Oxford BioDynamics Plc (LON:OBD – Get Free Report) was down 22.7% during trading on Wednesday . The stock traded as low as GBX 1.40 ($0.02) and last traded at GBX 1.70 ($0.02). Approximately 4,144,623 shares changed hands during trading, an increase of 124% from the average daily volume of 1,847,190 shares. The stock had previously closed at GBX 2.20 ($0.03).

Oxford BioDynamics Stock Performance

The company has a debt-to-equity ratio of 370.22, a quick ratio of 2.80 and a current ratio of 0.68. The firm’s 50-day moving average price is GBX 1.75 and its two-hundred day moving average price is GBX 5.05. The stock has a market cap of £4.27 million, a price-to-earnings ratio of -22.04 and a beta of 0.42.

Insider Buying and Selling at Oxford BioDynamics

In other news, insider David Holbrook purchased 49,653 shares of Oxford BioDynamics stock in a transaction dated Monday, October 28th. The shares were purchased at an average price of GBX 1 ($0.01) per share, with a total value of £496.53 ($633.57). 16.78% of the stock is currently owned by company insiders.

About Oxford BioDynamics

(Get Free Report)

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients.